康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09966 康宁杰瑞制药-B

收市竞价 10-21 16:02:20

7.375

+0.315

+4.46%

最高7.375	最低7.000	成交量345.30万
今开7.060	昨收7.060	日振幅5.31%
总市值71.24亿	流通市值71.24亿	总股本9.66亿
成交额2,455万	换手率0.36%	流通股本9.66亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09966","market":"HK","secType":"STK","nameCN":"康宁杰瑞制药-B","latestPrice":7.375,"timestamp":1792569730437,"preClose":7.06,"halted":0,"volume":3453000,"delay":0,"changeRate":0.04461756373937683,"floatShares":966000000,"shares":966000000,"eps":-0.12,"marketStatus":"收市竞价","change":0.315,"latestTime":"10-21 16:02:20","open":7.06,"high":7.375,"low":7,"amount":24553693,"amplitude":0.053116,"askPrice":7.375,"askSize":12000,"bidPrice":7.375,"bidSize":11000,"shortable":3,"etf":0,"ttmEps":-0.210595,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1792570200000},"marketStatusCode":4,"adr":0,"listingDate":1576080000000,"exchange":"SEHK","adjPreClose":7.06,"openAndCloseTimeList":[[1792546200000,1792555200000],[1792558800000,1792569600000]],"volumeRatio":2.59507,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09966","defaultTab":"news","newsList":[{"id":"1144349184","title":"康宁杰瑞制药-B回购14万股股份，耗资约94.34万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144349184","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144349184?lang=zh_cn&edition=full","pubTime":"2026-10-15 20:00","pubTimestamp":1792065655,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B（09966）于2026年10月15日回购公司股份14万股，占当日公司已发行股本的约0.0145%。本次回购的每股价格介于6.65港元至6.785港元之间，合计付出金额约94.34万港元。\n回购完成后，公司已发行股本变动至966,296,697股，库藏股数量增加至8,085,000股。本次回购根据公司于2026年6月12日获得的回购授权进行，截至目前已累计回购2,210,000股，剩余可回购额度为94,640,669股。公司确认已遵守香港联合交易所有关上市规则及其他适用法律规定。公告由执行董事徐霆签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B回购14万股股份，耗资约94.34万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675848725","title":"康宁杰瑞制药-B(09966.HK)10月15日耗资约94.34万港元回购14万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675848725","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675848725?lang=zh_cn&edition=full","pubTime":"2026-10-15 20:00","pubTimestamp":1792065641,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","09966","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675325345","title":"康宁杰瑞制药-B(09966)10月14日斥资97.49万港元回购14万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675325345","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675325345?lang=zh_cn&edition=full","pubTime":"2026-10-14 18:46","pubTimestamp":1791974770,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B(09966)发布公告，该公司于2026年10月14日斥资97.49万港元回购14万股股份，每股回购价格为6.895-7港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507214.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142935074","title":"康宁杰瑞制药-B10月14日回购14万股，耗资约97.49万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142935074","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142935074?lang=zh_cn&edition=full","pubTime":"2026-10-14 18:45","pubTimestamp":1791974751,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年10月14日发布公告，公司当日在香港联交所场内回购股份14万股，约占此前已发行股本的0.0145%。本次回购的股价区间为每股6.895港元至7港元，合计支付约97.49万港元。本次回购完成后，公司已发行股本由2026年9月30日的966,576,697股减少至966,436,697股，库藏股由7,805,000股增至7,945,000股。公司于2026年6月12日通过购回授权，授权最大可回购股份总数为96,850,669股，截至目前已在香港联交所或其他证券交易所合计回购2,070,000股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B10月14日回购14万股，耗资约97.49万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675810853","title":"兴业证券：维持康宁杰瑞制药-B(09966)“增持”评级 KN026商业化启航","url":"https://stock-news.laohu8.com/highlight/detail?id=2675810853","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675810853?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:33","pubTimestamp":1791793981,"startTime":"0","endTime":"0","summary":"2026年上半年，公司实现总收入2.71亿元(YoY-15.1%)，其中药品销售及特许权使用费收入0.74亿元，许可费收入1.91亿元","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20261012/20261012163518_96041.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20261012/20261012163518_96041.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["601377","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178627046","title":"康宁杰瑞制药-B更新9月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1178627046","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178627046?lang=zh_cn&edition=full","pubTime":"2026-10-05 16:37","pubTimestamp":1791189425,"startTime":"0","endTime":"0","summary":"近日，康宁杰瑞制药-B于2026年10月5日披露了截至2026年9月30日止的股份变动月报表，显示公司整体股本结构维持稳定。根据报告，康宁杰瑞制药-B本月底法定/注册股本与上月底保持一致，法定/注册股份总数为25,100,000,000股，每股面值为0.000002美元，法定/注册股本总额为50,200美元，未发生增减变动。期权及激励计划方面，首发前和首发后购股权计划均有少量失效或注销情形发生。回购股份均被列为库存股份，并未注销。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152900967","title":"康宁杰瑞制药-B：2026年9月28日回购5.8万股，涉资约46.49万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152900967","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152900967?lang=zh_cn&edition=full","pubTime":"2026-09-28 19:26","pubTimestamp":1790594780,"startTime":"0","endTime":"0","summary":"2026年9月28日，康宁杰瑞制药-B（09966）公告称，公司于当日在香港联交所场内回购普通股5.8万股，约占回购前已发行股本的0.006%。本次回购价格区间介乎每股港币7.99元至8.06元，合计耗资约46.49万港元。\n回购完成后，公司已发行股本由原先的9.66634697亿股减少至9.66576697亿股，同时库存股数增至780.5万股。公司于2026年6月12日通过购回授权，总额度为9685.0669万股，截至目前已累计回购193万股，占该购回授权通过当日已发行股本的0.1993%。\n公司确认本次股份购回符合香港联交所证券上市规则及相关法例。公告由执行董事徐霆签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B：2026年9月28日回购5.8万股，涉资约46.49万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670231222","title":"康宁杰瑞制药-B(09966)9月28日斥资46.5万港元回购5.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670231222","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670231222?lang=zh_cn&edition=full","pubTime":"2026-09-28 19:25","pubTimestamp":1790594735,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B(09966)发布公告，于2026年9月28日斥资46.5万港元回购5.8万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09966","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440905","title":"康宁杰瑞制药-B(09966)9月25日斥资29.03万港元回购3.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440905","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670440905?lang=zh_cn&edition=full","pubTime":"2026-09-25 20:44","pubTimestamp":1790340265,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B(09966)发布公告，该公司于2026年9月25日斥资29.03万港元回购3.5万股股份，每股回购价格为8.2-8.34港元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122218913","title":"康宁杰瑞制药-B9月25日回购3.50万股，耗资约29.03万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122218913","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122218913?lang=zh_cn&edition=full","pubTime":"2026-09-25 20:26","pubTimestamp":1790339172,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年9月25日发布翌日报表，宣布当日在香港联交所场内回购普通股3.50万股，回购价格区间为每股8.20港元至8.34港元，总耗资约29.03万港元。本次回购股份数量占该公司回购前已发行股本的约0.0036%。根据公告，回购股份事宜已于2026年6月12日经股东大会通过购回授权，发行人可根据该授权回购股份的总数为96,850,669股，截至目前，公司已累计回购1,872,000股。公司确认该项回购符合香港联合交易所有限公司的上市规则及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B9月25日回购3.50万股，耗资约29.03万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109151735","title":"康宁杰瑞制药-B2026年中期营收2.71亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1109151735","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109151735?lang=zh_cn&edition=full","pubTime":"2026-09-24 21:43","pubTimestamp":1790257416,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B发布2026年中期报告，营收录得2.71亿元人民币，同比下降约15%。报告期内毛利约2.45亿元，毛利率达到90.28%，与上年同期基本持平。经营活动现金流出现净流出0.61亿元，上年同期净流出约0.02亿元。销售及管理费用率略有下降，销售及管理费用约0.34亿元，同比降幅约1%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康宁杰瑞制药-B2026年中期营收2.71亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188227323","title":"创新药概念走高，云顶新耀、药明巨诺-B涨逾5%，金斯瑞生物科技涨逾4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188227323","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188227323?lang=zh_cn&edition=full","pubTime":"2026-09-23 11:01","pubTimestamp":1790132509,"startTime":"0","endTime":"0","summary":"9月23日，创新药概念走高，云顶新耀、药明巨诺-B涨逾5%，金斯瑞生物科技涨逾4%，康方生物、诺诚健华涨逾3%，基石药业涨逾2%，百济神州、药明生物、君实生物涨逾1%，信达生物跟涨。9月12-15日2026年世界肺癌大会召开，多项中国创新药临床数据集中亮相，康方生物依沃西单药OS数据、B7H3 ADC等成为焦点；与此同时，2026年国家医保目录谈判收官，商保创新药目录同步推进，支付端改革预期升温，\"出海商业化+支付改善\"的产业逻辑持续强化。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","09995","01801","03347","01672","02137","02269","09966","09688","00241","06996","06606","06622","06978","06618","02268","03759","02359"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1119094665","title":"康宁杰瑞制药-B于9月22日回购6万股，耗资约48.65万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119094665","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119094665?lang=zh_cn&edition=full","pubTime":"2026-09-22 19:32","pubTimestamp":1790076757,"startTime":"0","endTime":"0","summary":"2026年9月22日，康宁杰瑞制药-B在香港联合交易所发布翌日披露报表，宣布于当日以场内方式回购普通股合共60,000股，占回购日前已发行股份总数的约0.0062%。本次回购价格区间介于每股8.095港元至8.12港元，总耗资约48.65万港元。回购完成后，公司已发行股份数量为966,669,697股，库存股为7,712,000股，总发行股份数维持在974,381,697股。根据公告，公司已于2026年6月12日获得股东通过股份购回授权，可回购股份总数为96,850,669股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B于9月22日回购6万股，耗资约48.65万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669491191","title":"康宁杰瑞制药-B(09966.HK)9月22日斥资48.65万港元回购6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669491191","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669491191?lang=zh_cn&edition=full","pubTime":"2026-09-22 19:30","pubTimestamp":1790076621,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125550836","title":"康宁杰瑞制药-B回购12.40万股股份，耗资约95.03万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125550836","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125550836?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:02","pubTimestamp":1789732926,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年9月18日发布公告，披露当日于香港联交所场内回购公司股份12.40万股，占该公司回购前已发行股本约0.0128%。回购价格介乎每股7.625港元至7.70港元，总计耗资约95.03万港元。公告显示，回购完成后，公司已发行股份总数变动至966,729,697股，库藏股数量升至7,652,000股。公司确认有关回购行为符合香港联交所证券上市规则及相关法规的规定。本次公告由执行董事徐霆签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B回购12.40万股股份，耗资约95.03万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668792395","title":"康宁杰瑞制药-B(09966.HK)9月18日斥资95.03万港元回购12.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668792395","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668792395?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:01","pubTimestamp":1789732918,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09966","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176781780","title":"康宁杰瑞制药-B：9月17日回购12.40万股，耗资约96.31万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176781780","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176781780?lang=zh_cn&edition=full","pubTime":"2026-09-17 19:06","pubTimestamp":1789643175,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年9月17日发布公告称，当日公司在香港联交所场内回购普通股124,000股，占当日回购前已发行股本的约0.0128%。本次回购每股价格介乎7.68港元至7.87港元，总金额约96.31万港元。此前于2026年6月12日，公司相关购回授权已获股东大会批准，可回购股份的总数为96,850,669股，截至目前累计已回购1,653,000股。公司确认，本次回购行为已遵守香港联交所证券上市规则及相关法规。上述公告由执行董事徐霆签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B：9月17日回购12.40万股，耗资约96.31万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668694219","title":"康宁杰瑞制药-B(09966.HK)9月17日斥资96.31万港元回购12.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668694219","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668694219?lang=zh_cn&edition=full","pubTime":"2026-09-17 19:06","pubTimestamp":1789643165,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","09966","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165881447","title":"康宁杰瑞制药-B回购6.2万股股份，耗资约47.83万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165881447","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165881447?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:42","pubTimestamp":1789555338,"startTime":"0","endTime":"0","summary":"2026年9月16日，康宁杰瑞制药-B发布翌日披露报表，披露了最新的股份回购情况。根据公告，康宁杰瑞制药-B于2026年9月16日在香港联交所场内回购普通股6.2万股，占回购前已发行股本约0.0064%。回购价格介乎每股7.70港元至7.73港元，总耗资47.83万港元。回购完成后，公司已发行股本由9.67039697亿股降至9.66977697亿股，同时库藏股数量由734.2万股增至740.4万股。本次回购依据公司于2026年6月12日获得的购回授权进行，该授权最高可回购9,685.0669万股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B回购6.2万股股份，耗资约47.83万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185229625","title":"康宁杰瑞制药-B：9月15日回购12.2万股，耗资约96.73万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185229625","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185229625?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:45","pubTimestamp":1789472755,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B（09966）于2026年9月15日发布翌日披露报表，披露于香港联交所场内回购普通股122,000股，约占该日前已发行股本（不含库藏股）0.0126%。每股回购价格介乎7.895港元至8.005港元，总金额约96.73万港元。\n回购完成后，公司已发行股本（不含库藏股）为967,039,697股，库藏股数增至7,342,000股。根据公告，购回授权于2026年6月12日获股东大会批准，公司此前已通过该授权累计回购1,467,000股。公司确认已遵守香港联交所证券上市规则及相关法律法规。\n本公告由执行董事徐霆签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B：9月15日回购12.2万股，耗资约96.73万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphamab.com","stockEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":-0.089},{"period":"3month","weight":-0.0686},{"period":"6month","weight":-0.3845},{"period":"1year","weight":-0.4797},{"period":"ytd","weight":-0.2796}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":-0.0357},{"period":"3month","weight":-0.0412},{"period":"6month","weight":-0.079},{"period":"1year","weight":-0.077},{"period":"ytd","weight":-0.0688}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。该公司的内部管线由处于不同研发阶段的抗体偶联药物（ADC）、单克隆抗体及双特异性抗体肿瘤药物组成。该公司的产品管线包括KN046（PD-L1/CTLA-4双特异性抗体）、KN026（抗HER2双特异性抗体）、KN035（皮下注射PD-L1）、JSKN003（HER2双表位ADC）、JSKN016（HER3/TROP2双特异性抗体ADC）、JSKN033（JSKN003和KN035 的皮下复方制剂）等，用于1L sq NSCLC、1L HER2+乳腺癌、1L胆道癌、晚期实体瘤、HER2表达实体瘤等适应症。","yearOnYearQuotes":[{"month":1,"riseRate":0.142857,"avgChangeRate":-0.117313},{"month":2,"riseRate":0.571429,"avgChangeRate":0.192959},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.039472},{"month":4,"riseRate":0.857143,"avgChangeRate":0.098183},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.031094},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.059361},{"month":7,"riseRate":0.428571,"avgChangeRate":0.061567},{"month":8,"riseRate":0.428571,"avgChangeRate":0.047929},{"month":9,"riseRate":0.285714,"avgChangeRate":0.127495},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.049553},{"month":11,"riseRate":0.5,"avgChangeRate":0.042537},{"month":12,"riseRate":0.5,"avgChangeRate":-0.017716}],"exchange":"SEHK","name":"康宁杰瑞制药-B","nameEN":"ALPHAMAB-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康宁杰瑞制药-B,09966,康宁杰瑞制药-B股票,康宁杰瑞制药-B股票老虎,康宁杰瑞制药-B股票老虎国际,康宁杰瑞制药-B行情,康宁杰瑞制药-B股票行情,康宁杰瑞制药-B股价,康宁杰瑞制药-B股市,康宁杰瑞制药-B股票价格,康宁杰瑞制药-B股票交易,康宁杰瑞制药-B股票购买,康宁杰瑞制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}